Search Results - "Langguth, Peter"

Computer-aided Assurance of Risk Documentation within an Existing FMEA Landscape.

Alternate Title: Computergestützte Sicherung der Risikodokumentation innerhalb einer bestehenden FMEA-Landschaft.

Authors: Gattig, Philipp Langguth, Peter

Source: Pharmazeutische Industrie (Pharmind). 2019, Vol. 81 Issue 6, p851-856. 6p.

Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.

Authors: Zaheer, Kamran Langguth, Peter

Source: Drug Development & Industrial Pharmacy. Mar2018, Vol. 44 Issue 3, p444-451. 8p.

Transport processes of radiopharmaceuticals and -modulators.

Authors: Efferth, Thomas Langguth, Peter

Source: Radiation Oncology. 2011, Vol. 6 Issue 1, p59-68. 10p.

No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial.

Authors: Brüll, Verena Burak, Constanze Stoffel-Wagner, Birgit et al.

Source: European Journal of Nutrition. Oct2017, Vol. 56 Issue 7, p2265-2275.

Open‐Label, Randomized Pilot Study to Evaluate Safety and Tolerability of a Novel Dermal Nanoparticulate Imiquimod Formulation in the Treatment of Actinic Keratosis.

Authors: Lang, Berenice M. Meiser, Sophie Luise Hölzle, Isabella et al.

Source: Dermatologic Therapy. 5/12/2026, Vol. 2026, p1-14. 14p.

Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: a randomized, double-blind, placebo-controlled, crossover trial.

Authors: Brüll, Verena Burak, Constanze Stoffel-Wagner, Birgit et al.

Source: European Journal of Nutrition. Apr2017, Vol. 56 Issue 3, p1347-1357.

Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans.

Authors: Zimmermann, Benno Burak, Constanze Brüll, Verena et al.

Source: European Journal of Nutrition. Feb2017, Vol. 56 Issue 1, p343-353.

Life-Cycle-Management von Arzneimitteln in der deutschen Pharmaindustrie (Teil 2*)).

Authors: Trebbien, Sebastian Langguth, Peter Stieneker, Frank

Source: Pharmazeutische Industrie (Pharmind). 2014, Vol. 76 Issue 12, p1868-1873. 6p.

Life-Cycle-Management von Arzneimitteln in der deutschen Pharmaindustrie (Teil 1).

Authors: Trebbien, Sebastian Langguth, Peter Stieneker, Frank

Source: Pharmazeutische Industrie (Pharmind). 2014, Vol. 76 Issue 11, p1708-1713. 6p.

Aerosol Plumes of Inhalers Used in COPD.

Authors: Wachtel, Herbert Emerson-Stadler, Rachel Langguth, Peter et al.

Source: Pulmonary Therapy. Mar2024, Vol. 10 Issue 1, p109-122. 14p.

In Vitro-In Vivo Correlations.

Authors: Hühn, Eva Langguth, Peter

Source: Pharmazeutische Industrie (Pharmind). 2013, Vol. 75 Issue 2, p312-318. 6p. 1 Diagram.

Life-Cycle-Management von Arzneimitteln.

Authors: Trebbien, Sebastian Langguth, Peter Neubert, Reinhard et al.

Source: Pharmazeutische Industrie (Pharmind). 2012, Vol. 74 Issue 7, p1163-1170. 8p. 1 Diagram, 5 Charts, 4 Graphs.

FIP-Kongreß der Pharmazeutischen Wissenschaften.

Authors: Langguth, Peter

Source: Pharmazeutische Industrie (Pharmind). 2004, Vol. 66 Issue 9, p1133-1136. 4p.

In-vitro-Freisetzung von Diclofenac aus halbfesten Arzneiformen.

Authors: Becker, Martin Langguth, Peter Moll, Friedrich

Source: Pharmazeutische Industrie (Pharmind). 2003, Vol. 65 Issue 12, p1274-1278. 5p.

In Vitro Evaluation of Poly(D,L-lactide-co-glycolide) In Situ Gels and Pharmacokinetics Following Subcutaneous Injection in Rats for Model Drugs.

Authors: Van Hemelryck, Sandy Vercammen, Charlotte Seldeslachts, Eline et al.

Source: Pharmaceutics. Feb2026, Vol. 18 Issue 2, p219. 21p.

Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.

Authors: Zaheer, Kamran Langguth, Peter

Source: European Journal of Pharmaceutics & Biopharmaceutics. Jun2019, Vol. 139, p177-185. 9p.

Handling forces for the use of different inhaler devices.

Authors: Ciciliani, Anna-Maria Langguth, Peter Wachtel, Herbert

Source: International Journal of Pharmaceutics. Apr2019, Vol. 560, p315-321. 7p.

In vitro performances and cellular uptake of clarithromycin nanocrystals produced by media milling technique.

Authors: Soisuwan, Suwicha Teeranachaideekul, Veerawat Wongrakpanich, Amaraporn et al.

Source: Powder Technology; Oct2018, Vol. 338, p471-480, 10p

Dissimilar ferric derisomaltose formulations – In vitro comparisons between an originator and its intended similars.

Authors: Langguth, Peter Sharma, Reetesh Tulpule, Sameer et al.

Source: European Journal of Pharmaceutics & Biopharmaceutics. Oct2024, Vol. 203, pN.PAG-N.PAG. 1p.

Impact of Flow Restrictors on Aerosol Delivery of the Respimat® Soft Mist Inhaler.

Authors: Fleischhauer, Moritz Berkenfeld, Kai Stadermann, David et al.

Source: Pulmonary Therapy. Dec2025, Vol. 11 Issue 4, p605-623. 19p.